The cytokine storm of COVID-19: a spotlight on prevention and protection

10.1056/NEJMoa2001017

10.1080/22221751.2020.1719902

Source: ICNARC case mix programme database; 2020.

10.1016/S0140-6736(20)30566-3

10.1016/S0140-6736(20)30628-0

Hay KA, La¨ıla-A¨ıcha L, Hanafi A, et al. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy Key Points. 2017; [cited 2020 May 12]. Available from: https://ashpublications.org/blood/article-pdf/130/21/2295/1403588/blood793141.pdf

10.3349/ymj.2016.57.1.5

Merad M, Nat Rev Immunol

10.1371/journal.ppat.1007148

10.1016/j.celrep.2020.03.045

10.1038/s41577-020-0312-7

10.1016/j.cellimm.2018.09.008

10.3389/fimmu.2018.01545

10.1016/j.cytogfr.2020.04.002

Ye Q, 2020, COVID-19.’ J. Infect

10.1016/j.autrev.2020.102567

Mcgonagle D, Sharif K, O’regan A, et al. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. 2020; [cited 2020 May 17]. Available from: www.elsevier.com/locate/autrev

10.1101/cshperspect.a016295

10.1016/j.ijantimicag.2020.105954

Mahmud-Al-Rafat A, Majumder A, Rahman KMT, et al. Decoding the enigma of antiviral crisis: does one target molecule regulate all? 2018; [cited 2020 May 17]. Available from: www.elsevier.com/locate/cytokine

Falasca L, Agrati C, Petrosillo N, et al. Molecular mechanisms of Ebola virus pathogenesis: focus on cell death. Cell Death Differ. 2015;22(8):1250–1259

Yang ML, Sci Rep

10.1016/j.virusres.2007.02.007

10.7150/thno.30972

Perricone C, Triggianese P, Bartoloni E, et al. The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19. 2020; [cited 2020 May 18]; Available from: www.elsevier.com/locate/jautimm

10.1172/JCI137647

10.1089/jir.2008.0027

Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. 2020; [cited 2020 May 17]; Available from: https://doi.org/

10.1038/modpathol.3800247

10.1161/CIRCULATIONAHA.120.047525

Chieffo A, 2020, Eur Heart J, 41, 1839, 10.1093/eurheartj/ehaa381

Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. [cited 2020 May 18]. Available from: https://www.arcgis.com/apps/opsdash

10.1101/2020.04.07.20056788

10.1097/CCM.0b013e31820eb718

10.1056/NEJMc2009787

10.1038/ni.2001

10.1189/jlb.3RU0816-352RR

10.1016/j.yexmp.2020.104474

10.1128/JVI.78.7.3398-3406.2004

Danzi GB, Loffi M, Galeazzi G, et al. Acute pulmonary embolism and COVID-19 pneumonia: a random association?

Bertoletti L, 2020, Med Res, 78, 100759

10.1161/CIRCULATIONAHA.120.047430

10.5492/wjccm.v4.i2.105

Lemke G, 2020, Nat Rev Immunol, 1

10.1056/NEJMoa2007764

10.1016/S0140-6736(20)31022-9

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review [published online ahead of print, 2020 Apr 13]. JAMA. 2020;10.1001/jama.2020.6019

10.1001/jama.2020.8630

10.1007/s40265-017-0829-7

10.1002/jmv.25801

de Toni L, Garolla A, Di Nisio A, et al. Caution in the management of SARS-CoV-2 infection in males [published online ahead of print, 2020 May 26]. Andrology. 2020;10.1111

10.1016/j.cell.2020.02.052

10.1186/s13054-020-03055-6

Feng CG, 2019, Front Immunol, 1, 1393

10.1164/rccm.201101-0135OC

10.1016/S1473-3099(20)30141-9

Zheng Y, 2020, J Med Virol

10.1097/CCM.0b013e3182a2727d

10.1016/S2213-2600(20)30060-6

Kazory A, SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill, 10.1080/08998280.2020.1754700

10.1016/j.jss.2016.01.033

Hausenloy DJ, Yellon DM Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13(4):193–209

10.1016/S0140-6736(19)32039-2

Pickard JMJ, Davidson SM, Hausenloy DJ, et al. Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning.Basic Res Cardiol. 2016;111(4):50

Rossello X, The RISK pathway and beyond., 10.1007/s00395-017-0662-x

Bromage DI, Pickard JMJ, Rossello X, et al. Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis. Cardiovasc Res. 2017;113(3):288–297

10.1161/CIRCRESAHA.117.310820

Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53(1):31–47

10.1007/s10741-007-9026-1

Davidson SM, Ferdinandy P, Andreadou I, et al. Multitarget strategies to reduce myocardial ischemia/reperfusion injury JACC review topic of the week. J Am Coll Cardiol. 2019;73(1):89–99

10.1038/s41581-020-0284-7

10.3389/fphar.2020.00210

10.1056/NEJMoa1911303

Zhong J, Tan Y, Lu J, et al. Therapeutic contribution of melatonin to the treatment of septic cardiomyopathy: A novel mechanism linking Ripk3-modified mitochondrial performance and endoplasmic reticulum function. Redox Biol. 2019;26:101287

10.1002/1873-3468.13087

10.1016/j.tips.2007.04.006

10.1038/sj.bjp.0703809

10.3390/cells8090964